TSE:MFC

Manulife Financial (MFC.TO)

57.04
+0.49 (0.87%)
as of Jun 25, 2026, 8:00:00 pm Market Open.
1634 watching
0
Investor Insights
star iconJun 25, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed opinions from market experts. Many analysts recognize MFC's potential, particularly highlighting its growth in Asia and successful capital generation from legacy businesses. The consensus seems to indicate a solid long-term investment due to its steady dividend yield, with several experts suggesting that patience may be required as the stock navigates short-term fluctuations. Despite some concerns about past performance and market positioning against competitors, the company's strategy and management is viewed positively. Analysts mention the current valuation as reasonable compared to peers, suggesting MFC is a better option for income rather than growth. Overall, there is a cautious optimism about MFC's capabilities and future direction.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
SLF-T
DON'T BUY
Slightly overpriced. Doesn't agree with the market on the gains they are going to make with John Hancock. Prefers Sun Life (SLF-T) and Great West (GWO-T).
WEAK BUY
Looking at this one quite closely. The John Hancock acquisition has really vaulted it into a major North American player. Also likes its global exposure. Handled the Portis situation very well.
BUY
Prefers this company over Sun Life (SLF-T). Likes their global outlook. They have the top management in the industry in North America. John Hancock acquisition was a good one at a good price. Outlook for the life insurance industry is positive.
BUY
Great company. A global leader and great management. Rate of return between this and Sun Life (SLF-T) are quite similar and likes them both.
WEAK BUY
Interest rates will be going up. This tends to be bad for financials, but they have tools in place to hold problems to a minimum. Life companies will do better than banks. OK for a blue-chip portfolio or to balance a portfolio.
BUY
Has done a really tremendous job world wide and handled the John Hancock acquisition without a stumble.
TOP PICK
John Hancock was a good deal. Getting 5.19% yield. Trading at 15 X earnings. The Asian story is very important.
TOP PICK
Because of the large John Hancock acquisition, the market has perceived some issues with integration, so it has taken it down to below 2 X Book Value, so there's no premium in the stock anymore. At the $55 range or lower, he views it as the better opportunity for growth.
WATCH
There's a rising 200 day moving average. At the same time the MACD is giving a very negative signal. Financials are going to do very well for a short period of time. As long as it doesn't break down through $50 to $53 it gives hope that there will be a break on the upside.
WAIT
A great company. John Hancock acquisition was incredible. A global player in the insurance industry which makes a lot of sense. Great story long term, but short term, too much anticipation on their earnings and market will be disappointed. Would buy at 15% or so lower.
TOP PICK
Could be looking next year at $4.75 in earnings going forward. A terrific long term franchise that can grow internationaly.
BUY
Pull back is an opportunity to buy. Expects they will be buying stock back this year and a pretty big increase in the dividend. Should see growth in the core business. Asia is doing well for them.
BUY
Likes all 3 insurance companies, Manulife, Sun Life and Great west Life. Feels they are set to increase their dividends. All excellent companies.
PAST TOP PICK
(A Top Pick Nov 15/04. Up 1.5%.) Not all synergies have been met on the John Hancock deal, so their is still some steam left. Try to buy in the $54 range which would give yoiu a return of 15%.
BUY
His favourite in the insurance industry and the overall financial sector.
Showing 1,951 to 1,965 of 2,281 entries